Leti, Cellmic partner to speed market adoption of lens-free bioimaging

Leti, a research institute at CEA Tech (Grenoble, France), and Cellmic (Los Angeles, CA), a company dedicated to improving patient healthcare with smartphones and biophotonics, have joined forces to accelerate the market adoption of lens-free bioimaging and sensing techniques by growing Leti's patent portfolio with a core patent from Cellmic.

Related: Holographic microscope tracks sperm motion in 3D

Pioneered by Aydogan Ozcan, Chancellor's Professor at the University of California Los Angeles (UCLA), and his research group, the computational lens-free imaging approach reconstructs detailed images of specimens from their holographic shadows that contain unique 3D information of samples, such as tissue sections, blood smears, and cell cultures. Cellmic, a UCLA spinoff, holds some of the core patents of this computational imaging technique.

Lens-free microscopy has emerged as a powerful imaging and sensing platform that replaces bulky and expensive optical components that are found in standard optical microscopy systems with dedicated algorithms. Leti developed a lens-free microscope in 2012—today, the technology offers an ultra-wide field-of-view, tracking more than 10,000 biological, microscopic objects at a time per image, providing lab technicians with a cost-effective, highly compact, and robust solution. The Cellmic patent complements Leti’s IP portfolio and accelerates its ongoing valorization of its lens-free technology for diagnostics, biomedical sensing, and related applications.

For more information, please visit www.leti-cea.com, www.cellmic.com, and www.rapidassayreaders.com.